Its role in non-small-cell lung cancer (NSCLC) was elucidated by Feng et al. who suggested that hypermethylation of the promoter region of the S100A2 gene led to its downregulation in the early stages of NSCLC carcinogenesis thus contributing to tumor progression [68]. This evidence concerns the gene S100A2 and neoplasm.